These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25666264)

  • 1. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
    Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
    Schröder C; Schumacher U; Müller V; Wirtz RM; Streichert T; Richter U; Wicklein D; Milde-Langosch K
    Eur J Cancer; 2010 Jun; 46(9):1650-60. PubMed ID: 20226654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer.
    Arnold S; Kortland J; Maltseva DV; Nersisyan SA; Samatov TR; Lezius S; Tonevitsky AG; Milde-Langosch K; Wicklein D; Schumacher U; Stürken C
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1525-1542. PubMed ID: 34693476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.
    Kang SA; Hasan N; Mann AP; Zheng W; Zhao L; Morris L; Zhu W; Zhao YD; Suh KS; Dooley WC; Volk D; Gorenstein DG; Cristofanilli M; Rui H; Tanaka T
    Mol Ther; 2015 Jun; 23(6):1044-1054. PubMed ID: 25815697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
    Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
    Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
    Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
    Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
    Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
    Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
    Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
    Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
    Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
    Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
    Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
    Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
    Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
    Motrich RD; Castro GM; Caputto BL
    PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
    Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
    Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of soluble E-selectin on tumor progression and metastasis.
    Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
    BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
    Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
    Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
    Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.